2 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 2 |
Follow HER2 target therapy: new trials by email Literature Review of HER2 target therapy trials Research Report on HER2 target therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ADC Based Therapy Accroding to HER2 Heterogeneous HER2 target therapy - Breast Cancer (Early Breast Cancer) | Phase 2 | Not yet recruiting | Peking University People's Hospital | 88 | 2027-01-01 | 2026-10-02 |
| Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study FGFR Inhibitor, IDH1 mutation inhibitor, KRAS mutation inhibitor - Bile Duct Carcinoma, Cholangiocarcinoma | Phase 2 | Not yet recruiting | Zhejiang University | 240 | 2026-08-10 | 2026-07-28 |
Bile Duct Neoplasms (1) · Breast Neoplasms (1) · Cholangiocarcinoma (1)
Peking University People's Hospital (1) · Zhejiang University (1)
China (2)